Divella et al. (66) found that the number of CTCs was associated with TGF-β expression and showed that high TGF-β levels were associated with worse prognoses in breast cancer, supporting the finding that TGF-β promotes metastatic tumor growth and invasiveness (23). The gene discussed is TGFB1; the disease is breast carcinoma.